MACROGOL 3350 (TransiSoft®)

Clinical Indication

Chronic constipation, use usually limited to 2 weeks


Not to be confused with other macrogol products such as Macrogol oral powder compound e.g. Laxido or Movicol

Date of classification

April 2022


Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.